BURNABY, British Columbia, Nov. 28, 2016 -- Canlan Ice Sports Corp. (TSX:ICE), industry-leading providers of recreational facilities across North America, today announced it has approved the continuation of the Company’s quarterly dividend policy and declared eligible dividends totaling $0.02 per common share that will next be paid on January 17, 2017 to shareholders of record at the close of business December 30, 2016. Canlan's Board of Directors reviews the Company's dividend policy on a quarterly basis.
Canlan's dividend is designated as an “eligible” dividend under the Income Tax Act (Canada) and any corresponding provincial legislation. Under this legislation, individuals resident in Canada may be entitled to enhanced dividend tax credits, which reduce income tax otherwise payable.
About Canlan
Canlan Ice Sports Corp. is the North American leader in the development, operations and ownership of ice rink and multi-purpose recreation facilities. Canlan is the largest private sector owner and operator of multi-sport facilities in North America and currently owns and/or manages 20 facilities in Canada and the United States with 57 ice surfaces, as well as indoor soccer fields, sport courts, volleyball, and basketball courts. To learn more about Canlan please visit www.icesports.com.
For more information: Canlan Ice Sports Corp. Michael F. Gellard Senior Vice President & CFO 604-736-9152


SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Leapmotor Targets 4 Million Annual EV Sales as Global Expansion Accelerates 



